1 Market Overview

1.1 Product Overview and Scope of Pharmaceutics and Novel Drug Delivery Systems

1.2 Classification of Pharmaceutics and Novel Drug Delivery Systems by Type

1.2.1 Overview: Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type in 2020

1.2.3 Liposomes

1.2.4 PEGylated Proteins & Polypeptides

1.2.5 Polymer Nanoparticle

1.2.6 Protein–drug Conjugates

1.2.7 Other

1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market by Application

1.3.1 Overview: Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals & Clinic

1.3.3 Cancer Treatment Centers

1.3.4 Others

1.4 Global Pharmaceutics and Novel Drug Delivery Systems Market Size & Forecast

1.5 Global Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast by Region

1.5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region, (2016-2021)

1.5.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size and Prospect (2016-2026)

1.5.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size and Prospect (2016-2026)

1.5.6 South America Pharmaceutics and Novel Drug Delivery Systems Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Pharmaceutics and Novel Drug Delivery Systems Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceutics and Novel Drug Delivery Systems Market Drivers

1.6.2 Pharmaceutics and Novel Drug Delivery Systems Market Restraints

1.6.3 Pharmaceutics and Novel Drug Delivery Systems Trends Analysis

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.1.4 Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Recent Developments and Future Plans

2.2 Teva

2.2.1 Teva Details

2.2.2 Teva Major Business

2.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.2.4 Teva Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Teva Recent Developments and Future Plans

2.3 Roche

2.3.1 Roche Details

2.3.2 Roche Major Business

2.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.3.4 Roche Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Roche Recent Developments and Future Plans

2.4 UCB (Union Chimique Belge)

2.4.1 UCB (Union Chimique Belge) Details

2.4.2 UCB (Union Chimique Belge) Major Business

2.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.4.4 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 UCB (Union Chimique Belge) Recent Developments and Future Plans

2.5 Celgene

2.5.1 Celgene Details

2.5.2 Celgene Major Business

2.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.5.4 Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Celgene Recent Developments and Future Plans

2.6 Merck

2.6.1 Merck Details

2.6.2 Merck Major Business

2.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.6.4 Merck Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Merck Recent Developments and Future Plans

2.7 Gilead Sciences

2.7.1 Gilead Sciences Details

2.7.2 Gilead Sciences Major Business

2.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.7.4 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Gilead Sciences Recent Developments and Future Plans

2.8 Sanofi

2.8.1 Sanofi Details

2.8.2 Sanofi Major Business

2.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.8.4 Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Sanofi Recent Developments and Future Plans

2.9 Pfizer

2.9.1 Pfizer Details

2.9.2 Pfizer Major Business

2.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.9.4 Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Pfizer Recent Developments and Future Plans

2.10 Takeda

2.10.1 Takeda Details

2.10.2 Takeda Major Business

2.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.10.4 Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Takeda Recent Developments and Future Plans

2.11 Bausch&Lomb

2.11.1 Bausch&Lomb Details

2.11.2 Bausch&Lomb Major Business

2.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.11.4 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Bausch&Lomb Recent Developments and Future Plans

2.12 Samyang Biopharmaceuticals

2.12.1 Samyang Biopharmaceuticals Details

2.12.2 Samyang Biopharmaceuticals Major Business

2.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.12.4 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Samyang Biopharmaceuticals Recent Developments and Future Plans

2.13 Johnson & Johnson

2.13.1 Johnson & Johnson Details

2.13.2 Johnson & Johnson Major Business

2.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.13.4 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Johnson & Johnson Recent Developments and Future Plans

2.14 TOLMAR

2.14.1 TOLMAR Details

2.14.2 TOLMAR Major Business

2.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.14.4 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 TOLMAR Recent Developments and Future Plans

2.15 Astellas

2.15.1 Astellas Details

2.15.2 Astellas Major Business

2.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.15.4 Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Astellas Recent Developments and Future Plans

2.16 AMAG Pharmaceuticals

2.16.1 AMAG Pharmaceuticals Details

2.16.2 AMAG Pharmaceuticals Major Business

2.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.16.4 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 AMAG Pharmaceuticals Recent Developments and Future Plans

2.17 AbbVie

2.17.1 AbbVie Details

2.17.2 AbbVie Major Business

2.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.17.4 AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 AbbVie Recent Developments and Future Plans

2.18 Dr Reddy

2.18.1 Dr Reddy Details

2.18.2 Dr Reddy Major Business

2.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.18.4 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Dr Reddy Recent Developments and Future Plans

2.19 AstraZeneca

2.19.1 AstraZeneca Details

2.19.2 AstraZeneca Major Business

2.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.19.4 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 AstraZeneca Recent Developments and Future Plans

2.20 Aspen

2.20.1 Aspen Details

2.20.2 Aspen Major Business

2.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.20.4 Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Aspen Recent Developments and Future Plans

2.21 Acrotech Biopharma

2.21.1 Acrotech Biopharma Details

2.21.2 Acrotech Biopharma Major Business

2.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.21.4 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Acrotech Biopharma Recent Developments and Future Plans

2.22 TWi Pharmaceuticals

2.22.1 TWi Pharmaceuticals Details

2.22.2 TWi Pharmaceuticals Major Business

2.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

2.22.4 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 TWi Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceutics and Novel Drug Delivery Systems Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceutics and Novel Drug Delivery Systems Players Market Share

3.2.2 Top 10 Pharmaceutics and Novel Drug Delivery Systems Players Market Share

3.2.3 Market Competition Trend

3.3 Pharmaceutics and Novel Drug Delivery Systems Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceutics and Novel Drug Delivery Systems Revenue and Market Share by Type (2016-2021)

4.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application (2016-2021)

5.2 Pharmaceutics and Novel Drug Delivery Systems Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2026)

6.2 North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2026)

6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country

6.3.1 North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2026)

6.3.2 United States Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

6.3.3 Canada Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

6.3.4 Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2026)

7.2 Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2026)

7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country

7.3.1 Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2026)

7.3.2 Germany Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

7.3.3 France Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

7.3.5 Russia Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

7.3.6 Italy Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2026)

8.2 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2026)

8.3 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Market Size by Region

8.3.1 Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Region (2016-2026)

8.3.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8.3.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8.3.4 South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8.3.5 India Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

8.3.7 Australia Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2026)

9.2 South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2026)

9.3 South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country

9.3.1 South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2026)

9.3.2 Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

9.3.3 Argentina Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2026)

10.2 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2026)

10.3 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Market Size by Country

10.3.1 Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2026)

10.3.2 Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

10.3.4 UAE Pharmaceutics and Novel Drug Delivery Systems Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Pharmaceutics and Novel Drug Delivery Systems Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) by Region (2016-2021)

Table 5. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Region (2021-2026)

Table 6. Amgen Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Major Business

Table 8. Amgen Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 9. Amgen Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Teva Corporate Information, Head Office, and Major Competitors

Table 11. Teva Major Business

Table 12. Teva Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 13. Teva Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Roche Corporate Information, Head Office, and Major Competitors

Table 15. Roche Major Business

Table 16. Roche Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 17. Roche Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. UCB (Union Chimique Belge) Corporate Information, Head Office, and Major Competitors

Table 19. UCB (Union Chimique Belge) Major Business

Table 20. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 21. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Celgene Corporate Information, Head Office, and Major Competitors

Table 23. Celgene Major Business

Table 24. Celgene Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 25. Celgene Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Merck Corporate Information, Head Office, and Major Competitors

Table 27. Merck Major Business

Table 28. Merck Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 29. Merck Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Gilead Sciences Corporate Information, Head Office, and Major Competitors

Table 31. Gilead Sciences Major Business

Table 32. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 33. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Sanofi Corporate Information, Head Office, and Major Competitors

Table 35. Sanofi Major Business

Table 36. Sanofi Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 37. Sanofi Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Pfizer Corporate Information, Head Office, and Major Competitors

Table 39. Pfizer Major Business

Table 40. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 41. Pfizer Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Takeda Corporate Information, Head Office, and Major Competitors

Table 43. Takeda Major Business

Table 44. Takeda Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 45. Takeda Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Bausch&Lomb Corporate Information, Head Office, and Major Competitors

Table 47. Bausch&Lomb Major Business

Table 48. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 49. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Samyang Biopharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 51. Samyang Biopharmaceuticals Major Business

Table 52. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 53. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 55. Johnson & Johnson Major Business

Table 56. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 57. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. TOLMAR Corporate Information, Head Office, and Major Competitors

Table 59. TOLMAR Major Business

Table 60. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 61. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Astellas Corporate Information, Head Office, and Major Competitors

Table 63. Astellas Major Business

Table 64. Astellas Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 65. Astellas Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. AMAG Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 67. AMAG Pharmaceuticals Major Business

Table 68. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 69. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. AbbVie Corporate Information, Head Office, and Major Competitors

Table 71. AbbVie Major Business

Table 72. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 73. AbbVie Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Dr Reddy Corporate Information, Head Office, and Major Competitors

Table 75. Dr Reddy Major Business

Table 76. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 77. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 79. AstraZeneca Major Business

Table 80. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 81. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Aspen Corporate Information, Head Office, and Major Competitors

Table 83. Aspen Major Business

Table 84. Aspen Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 85. Aspen Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Acrotech Biopharma Corporate Information, Head Office, and Major Competitors

Table 87. Acrotech Biopharma Major Business

Table 88. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 89. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. TWi Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 91. TWi Pharmaceuticals Major Business

Table 92. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product and Solutions

Table 93. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. Global Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) by Players (2019-2021)

Table 95. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Players (2019-2021)

Table 96. Breakdown of Pharmaceutics and Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. Pharmaceutics and Novel Drug Delivery Systems Players Head Office, Products and Services Provided

Table 98. Pharmaceutics and Novel Drug Delivery Systems Mergers & Acquisitions in the Past Five Years

Table 99. Pharmaceutics and Novel Drug Delivery Systems New Entrants and Expansion Plans

Table 100. Global Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) by Type (2016-2021)

Table 101. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Type (2016-2021)

Table 102. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Forecast by Type (2021-2026)

Table 103. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021)

Table 104. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Forecast by Application (2021-2026)

Table 105. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2021) & (USD Million)

Table 106. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)

Table 107. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021) & (USD Million)

Table 108. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)

Table 109. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2021) & (USD Million)

Table 110. North America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)

Table 111. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2021) & (USD Million)

Table 112. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)

Table 113. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021) & (USD Million)

Table 114. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)

Table 115. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2021) & (USD Million)

Table 116. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)

Table 117. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2021) & (USD Million)

Table 118. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)

Table 119. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021) & (USD Million)

Table 120. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)

Table 121. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Region (2016-2021) & (USD Million)

Table 122. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue by Region (2021-2026) & (USD Million)

Table 123. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2021) & (USD Million)

Table 124. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)

Table 125. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021) & (USD Million)

Table 126. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)

Table 127. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2021) & (USD Million)

Table 128. South America Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)

Table 129. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2016-2021) & (USD Million)

Table 130. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Type (2021-2026) & (USD Million)

Table 131. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2016-2021) & (USD Million)

Table 132. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Application (2021-2026) & (USD Million)

Table 133. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2016-2021) & (USD Million)

Table 134. Middle East & Africa Pharmaceutics and Novel Drug Delivery Systems Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Pharmaceutics and Novel Drug Delivery Systems Picture

Figure 2. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type in 2020

Figure 3. Liposomes

Figure 4. PEGylated Proteins & Polypeptides

Figure 5. Polymer Nanoparticle

Figure 6. Protein–drug Conjugates

Figure 7. Other

Figure 8. Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Application in 2020

Figure 9. Hospitals & Clinic Picture

Figure 10. Cancer Treatment Centers Picture

Figure 11. Others Picture

Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Region (2016-2026)

Figure 15. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Region in 2020

Figure 16. North America Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Pharmaceutics and Novel Drug Delivery Systems Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Pharmaceutics and Novel Drug Delivery Systems Market Drivers

Figure 22. Pharmaceutics and Novel Drug Delivery Systems Market Restraints

Figure 23. Pharmaceutics and Novel Drug Delivery Systems Market Trends

Figure 24. Amgen Recent Developments and Future Plans

Figure 25. Teva Recent Developments and Future Plans

Figure 26. Roche Recent Developments and Future Plans

Figure 27. UCB (Union Chimique Belge) Recent Developments and Future Plans

Figure 28. Celgene Recent Developments and Future Plans

Figure 29. Merck Recent Developments and Future Plans

Figure 30. Gilead Sciences Recent Developments and Future Plans

Figure 31. Sanofi Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Takeda Recent Developments and Future Plans

Figure 34. Bausch&Lomb Recent Developments and Future Plans

Figure 35. Samyang Biopharmaceuticals Recent Developments and Future Plans

Figure 36. Johnson & Johnson Recent Developments and Future Plans

Figure 37. TOLMAR Recent Developments and Future Plans

Figure 38. Astellas Recent Developments and Future Plans

Figure 39. AMAG Pharmaceuticals Recent Developments and Future Plans

Figure 40. AbbVie Recent Developments and Future Plans

Figure 41. Dr Reddy Recent Developments and Future Plans

Figure 42. AstraZeneca Recent Developments and Future Plans

Figure 43. Aspen Recent Developments and Future Plans

Figure 44. Acrotech Biopharma Recent Developments and Future Plans

Figure 45. TWi Pharmaceuticals Recent Developments and Future Plans

Figure 46. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Players in 2020

Figure 47. Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 48. Global Top 3 Players Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share in 2020

Figure 49. Global Top 10 Players Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share in 2020

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 51. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Type in 2020

Figure 52. Global Pharmaceutics and Novel Drug Delivery Systems Market Share Forecast by Type (2021-2026)

Figure 53. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Application in 2020

Figure 54. Global Pharmaceutics and Novel Drug Delivery Systems Market Share Forecast by Application (2021-2026)

Figure 55. North America Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Type (2016-2026)

Figure 56. North America Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Application (2016-2026)

Figure 57. North America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Country (2016-2026)

Figure 58. United States Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Canada Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Mexico Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Europe Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Type (2016-2026)

Figure 62. Europe Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Application (2016-2026)

Figure 63. Europe Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Country (2016-2026)

Figure 64. Germany Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. France Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. United Kingdom Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Russia Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Italy Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Type (2016-2026)

Figure 70. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Application (2016-2026)

Figure 71. Asia-Pacific Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Region (2016-2026)

Figure 72. China Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Japan Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Korea Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. India Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Australia Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South America Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Type (2016-2026)

Figure 79. South America Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Application (2016-2026)

Figure 80. South America Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Country (2016-2026)

Figure 81. Brazil Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Argentina Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Middle East and Africa Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Type (2016-2026)

Figure 84. Middle East and Africa Pharmaceutics and Novel Drug Delivery Systems Sales Market Share by Application (2016-2026)

Figure 85. Middle East and Africa Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Country (2016-2026)

Figure 86. Turkey Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. UAE Pharmaceutics and Novel Drug Delivery Systems Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source